RESEARCH TRIANGLE PARK, N.C., March 21, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (“Opus” or the “Company”) (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and therapies for other ophthalmic disorders, today announced the pricing of an underwritten public offering… Read More..

SANTA BARBARA, CA, March 21, 2025 – PRISM MediaWire – Today DRYWORLD Brands Inc. (OTC PINK: IBGR), a leading performance athletic brand, has announced the debut of its “Innovation that Elevates” campaign which introduces its new revolutionary graduated compression apparel designed to enhance the performance of elite athletes. The launch… Read More..

IRVINE, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a pioneering diagnostics technology company, today announced that it will report fourth quarter 2024 financial results after the market closes on Monday, March 24, 2025. Oncocyte will host a live Zoom webinar to discuss the company's financial results… Read More..